Open Access

Subtilisin QK-2: secretory expression in Lactococcus lactis and surface display onto gram-positive enhancer matrix (GEM) particles

Microbial Cell Factories201615:80

Received: 4 March 2016

Accepted: 3 May 2016

Published: 12 May 2016



Purified from the supernatant of Bacillus subtilis QK02 culture broth, Subtilisin QK-2 is a type of effective thrombolytic reagent that has great exploitable potential. However, the unbearable flavor that occurs with fermentation and the complicated methods that are required to obtain pure products limit the application of this enzyme. Lactic acid bacteria (LAB)-based delivery vehicles are promising as cheap and safe options for medicinal compounds. The secretory expression and surface display using LAB may popularize Subtilisin QK-2 more easily and conveniently with minimal adverse effects.


Subtilisin QK-2 was expressed successfully in two forms using lactic acid bacteria. For the secretory expression in Lactococcus lactis, Subtilisin QK-2 was efficiently secreted into the culture using the promoter P nisA and signal peptide SPUsp. The expression levels were not different in L. lactis NZ9000 and NZ3900 without the effect of different selection markers. However, leaky expression was only detected in L. lactis NZ3900. The biological activity of this secreted Subtilisin QK-2 was enhanced by modulating the pH of medium to slightly alkaline during induction and by codon optimization of either the entire gene sequence (qk′) or only the propeptide gene sequence (qkpro′). For surface display onto gram-positive enhancer matrix (GEM) particles, n LysM repeats from the C-terminal region of the major autolysin AcmA of L. lactis were fused to either the C-terminus (n = 1, 3, 5) or the N-terminus (n = 1) of the Subtilisin QK-2. These fusion proteins were secreted into the culture medium, and the QK-3LysM was able to bind to the surface of various LAB GEM particles without a loss of fibrinolytic activity. Furthermore, the binding capacity significantly increased with a higher concentration of QK-3LysM. Compared to the free-form Subtilisin QK-2, the QK-3LysM displayed on the surface of GEM particles was more stable in the simulated gastric juice.


Combined with the safety and popularity of LAB, Subtilisin QK-2 may be easily applied worldwide to prevent and control thrombosis diseases.


Subtilisin QK-2 Lactic acid bacteria Secretory expression Surface display Gram-positive enhancer matrix Thrombus


Microbial fibrinolytic enzymes have recently attracted greater attention for thrombolytic therapy. As a homolog to Nattokinase (EC, Subtilisin QK-2 was purified from the supernatant of Bacillus subtilis QK02 culture broth. Mature Subtilisin QK-2 consists of 275 amino acid residues (MW = 27.8 kDa) and shows high efficiency for directly cross-linked fibrin degradation, as determined by SDS-PAGE and the fibrin plate method in vitro [1]. Subtilisin QK-2 inhibits tyrosine nitration induced by nitrite, hydrogen peroxide and hemoglobin in vitro and in vivo and protects human umbilical vein endothelial cells (ECV-304) from damage caused by nitrite and hydrogen peroxide [2]. Additionally, Subtilisin QK-2 significantly inhibits thrombus formation and displays strong thrombolytic activity in mice, and its effect is better than that of the clinically used lumbrokinase [3]. Therefore, Subtilisin QK-2 is a type of effective thrombolytic reagent with great exploitable potential, similar to Nattokinse.

Lactic acid bacteria (LAB), which are widely used in the food industry, are present in the intestines of most animals, including humans. Because many have been granted “generally regarded as safe” (GRAS) status, these bacteria can be used as live vehicles for antigenic, functional proteins or for DNA delivery to the mucosal surface [4]. As the best-studied LAB over the last two decades, Lactococcus lactis is an ideal bacteria for the food-grade production of recombinant proteins, and many expression systems have been developed and used in the production of heterologous proteins in L. lactis [5]. One of the most powerful expression systems used in LAB is the nisin controlled expression (NICE) system, which is based on the genes involved in the biosynthesis and regulation of the antimicrobial peptide, nisin [4]. Using the NICE system, heterologous proteins can be targeted to a specific cell location, including the cytoplasm, cell surface or extracellular medium. By evaluating the influence of localization on the production yields in L. lactis, it was concluded that secretion is preferable to cytoplasmic production [6]. The absence of an outer membrane in LAB makes them particularly attractive for exposing bioactive molecules to the extracellular compartment. Anchoring proteins or peptides onto the surface of LAB is promising in various fields of biotechnological applications [7]. Depending on whether it is genetically modified, surface-engineered LAB can be divided into two types, a genetically modified organism (GMO) and a non-living and non-genetically modified gram-positive bacterial delivery particle, which is also referred to as gram-positive enhancer matrix (GEM). For the GMO type, the expression and display of the passenger protein occurs in the same cell that contains the passenger and anchor fusion gene in the expression plasmid or the genome. By contrast, the expression and display of the fusion protein for the GEM type are separated, such that this type needs two different cells, one cell expresses the fusion protein, and the pretreated LAB cell is combined with the fusion protein to bind the anchor to the surface of the GEM particle using the anchor domain contained in the fusion protein [8]. The expression strain can be yeast or Escherichia coli in addition to LAB. The LysM repeat exists in the C-terminal region of the major autolysin AcmA (GenBank: U17696.1) of L. lactis and is the anchor domain that is most frequently used to display proteins or peptides on GEM particles [812]. Fused with the LysM anchor domain to its C-terminus, α-amylase of Bacillus licheniformis is secreted into the culture medium by L. lactis NZ9000 and can bind to the surface of trichloroacetic acid (TCA)-pretreated LAB GEM particles without a loss of its functional activity [10]. To promote the application of Subtilisin QK-2, we report the secreted expression of this enzyme in L. lactis and surface display onto various LAB GEM particles.


Construction of QK-secreting and QK-displaying plasmids

All plasmids constructed in this study are shown in Fig. 1. All plasmids contain the Usp45 signal peptide sequence (sp Usp), which enables protein secretion, and is driven by the inducible promoter P nisA . For secretion of the free Subtilisin QK-2, the wild qk, the codon-optimized qk′ and the only optimized propeptide sequence qkpro′ (a gene sequence alignment diagram can be found in Additional file 1: Figure S1), were included as shown in Fig. 1b. The LysM repeats from the acmA of L. lactis MG1363 were fused with the qk gene to display this serine protease onto the surface of LAB GEM particles. As shown in Fig. 1d, the nLysM repeats were fused either to the C-terminus (n = 1, 3, 5) or the N-terminus (n = 1) of Subtilisin QK-2.
Fig. 1

Schematic illustration of proteins or vectors. a Schematic illustration of the Subtilisin QK-2 protein. SP signal peptide; P propeptide; M mature peptide. b Schematic illustration of secretory expression vectors. P nisA promoter; SPusp secretion signal sequence for L. lactis; qk (b-1) wild-type gene; qk′ (b-2) the entire gene sequence with codon optimization; qkpro’ (b-3) the only codon-optimized propeptide gene sequence. (b-1) contains plasmids pRF02, pRF02H, pRF03 and pRF03H. (b-2) indicates plasmid pRF04H. (b-3) indicates plasmid pRF05H. c Schematic illustration of the AcmA protein. S.S. signal sequence; A.D. active domain; LysM anchoring repeats; d schematic illustration of vectors for surface display. (d-1), (d-2), (d-3) and (d-4) indicate plasmids pRF06H, pRF07H, pRF08H and pRF09H, respectively. pRF02 and pRF02H were selected by the complementation of the lacF gene and others were selected by the chloramphenicol resistant gene. H his-tag

Secretory expression of free Subtilisin QK-2

Under the optimized induction conditions (Additional file 1: Figure S2), nisin (70 ng/ml) was added for induction when the OD600 of the culture reached approximately 0.5. Then, the culture was incubated at 30 °C for 8 h. A specific band of 28 kDa (identical to the molecular mass of mature Subtilisin QK-2) was detected by western blotting analysis of the supernatant of the induced culture (Fig. 2a) but not in the intracellular lysate (data not shown). The resulting fibrinolytic activity reached approximately 52.3 urokinase units per milliliter culture (Figs. 2b, 3). By testing the fibrinolytic activity of the supernatant culture and the intracellular lysate, secretion efficiency was evaluated, and approximately 96 % of the Subtilisin QK-2 was secreted into the medium. Interestingly, the specific protein bands in the western blot and clearing zones in the fibrinolytic activity analysis were detected not only in the supernatant of the induced culture but also in the non-induced culture of L. lactis NZ3900 (pRF02/pRF02H/pRF03H) (Figs. 2, 3). However, Subtilisin QK-2 was detected only in the induced L. lactis NZ9000. Under the optimized induction conditions, the expression levels in NZ9000 and NZ3900 were approximately the same, regardless of the selection method used (Fig. 3). By comparing the fibrinolytic activity of the protein samples with the His-tag or untagged proteins (Fig. 3), it was concluded that the His-tag did not interfere with the production or activity of this expressed protein.
Fig. 2

Western blotting analysis (a) and fibrinolytic activity analysis (b) of Subtilisin QK-2 expressed in L. lactis. 1 five times concentrated supernatant of noninduced L. lactis NZ3900 (pRF02H); 2 supernatant of induced L. lactis NZ3900 (pRF02H); 3 five times concentrated supernatant of noninduced L. lactis NZ3900 (pRF03H); 4 supernatant of induced L. lactis NZ3900 (pRF03H); 5 five times concentrated supernatant of noninduced L. lactis NZ9000 (pRF03H); 6 supernatant of induced L. lactis NZ9000 (pRF03H); 7 supernatant culture of the Bacillus subtilis QK02. The protein amounts analyzed in western blot were three times that of the fibrinolytic activity analysis

Fig. 3

Fibrinolytic activity analysis of different recombinant L. lactis strains under the indicated induction conditions. pH modulation indicates that addition of NaOH into the medium at 3 h after induction; (−) meaning without pH modulation, (+) meaning with pH modulation. All data presented were mean ± SD of three replicate experiments (*p < 0.05)

Effect of pH modulation on Subtilisin QK-2 expression

Subtilisin QK-2 is an alkaline protease, and the pH of the medium may play an important role in the expression of this protease. To regulate the pH of the medium, NaOH was added once at 1, 2, or 3 h after induction. The early addition of NaOH (at 1 or 2 h) has an inhibitory effect on growth, as determined by the OD600 readings (data not shown). By adding NaOH at 3 h after induction, the ending pH of the medium was 7.3–7.9, and a higher fibrinolytic activity (p < 0.05) was detected as shown in Fig. 3.

Codon usage analysis and effect of codon optimization

The results of the codon usage analysis showed that there are only 23 “low” (10–20 %) usage frequency codons and no “very low” (<10 %) usage frequency codons in the codons of the qk gene, as defined in Methods; and that the percentage of “unfavorable” codons is only approximately 6.5 % (23 in 353). Of these 23 rare codons, 11 codons appear in the first 106 codons, which encode the propeptide sequence. Both the wild-type Subtilisin QK-2 gene (qk) and the codon-optimized gene (qk′ and qkpro′) were expressed in the same way, and the results were used to study the effect of codon optimization on heterologous expression in L. lactis. Compared to the wild-type Subtilisin QK-2 expressed in L. lactis NZ9000 (pRF03H), stronger fibrinolytic activity (p < 0.05) was detected in the induced culture of L. lactis NZ9000 (pRF04H) and NZ9000 (pRF05H) (Fig. 3). The fibrinolytic activity detected in L. lactis NZ9000 (pRF04H) and NZ9000 (pRF05H) was similar (Fig. 3). Although the bioactivity of the expressed Subtilisin QK-2 was improved by pH modulation or codon optimization, no visible specific protein band was observed by SDS-PAGE analysis, and the protein bands detected in the western blotting analysis, even for the 50-fold concentrated samples, were comparable to these with no pH modulation or codon optimization (data not shown).

Expression and characterization of fusion proteins

To use the anchor ability of the LysM repeat, four different plasmids were constructed and transformed into L. lactis NZ9000. After induction with no pH modulation, the supernatant was used for western blotting analysis and the results are shown in Fig. 4. All C-terminus fusion samples (QK-1LysM, QK-3LysM, QK-5LysM) showed immunoreactive protein bands of 35, 51 and 66 kDa, respectively, which were the expected size of the recombinant proteins. However, degradation was observed in the protein samples from L. lactis NZ9000 (pRF08H), which contained five LysM repeats (QK-5LysM). For the N-terminus fusion protein sample (1LysM-QK), a 44 kDa protein band was detected, which was larger than the expected size of 35 kDa. Analysis of the fibrinolytic activity of these fusion proteins showed that only the C-terminus fusion samples maintained their enzymatic activity; of these three fusion proteins, the enzymatic activity of QK-1LysM and QK-3LysM was approximately 85.7 and 82.4 %, respectively of the free form Subtilisin QK-2 expressed in L. lactis NZ9000 (pRF03H), and the activity of QK-5LysM was significantly decreased (Table 1). Therefore, the binding assay was performed with the QK-1LysM and QK-3LysM fusion proteins.
Fig. 4

Western blotting analysis of the fusion proteins from the induced supernatant. 1 cells harboring pRF06H expressing QK-1LysM; 2 cells harboring pRF07H expressing QK-3LysM; 3 cells harboring pRF08H expressing QK-5LysM; 4 cells harboring pRF09H expressing 1LysM-QK; 5 cells harboring pNZ8048, negative control. The right arrows indicated the expected size, respectively

Table 1

Fibrinolytic activity of different form QK


Activity (U/ml)

Percentage (%)

Subtilisin QK-2














Binding of QK-1LysM and QK-3LysM to LAB GEM particles

After incubation with 5 ml cell-free culture medium containing QK-1LysM or QK-3LysM, loaded GEM particles were washed and used for western blotting analysis and measure of fibrinolytic activity, as described in the “Methods” section. The GEM samples that were not incubated with the fusion protein or for those incubated with the free Subtilisin QK-2 exhibited no protein bands (data not shown). Both fusion proteins bound to the GEM particles; however, the binding of QK-1LysM was poor because a considerable amount of this fusion protein remained in the culture medium after binding, as shown in Additional file1: Figure S3. By contrast, the protein amounts of the QK-3LysM bound to various LAB GEM particles were higher as determined by western blot and analysis of the fibrinolytic activity (Fig. 5). The binding efficiency calculated by western blot and analysis of the fibrinolytic activity was similar for the corresponding LAB GEM particles. The results show that the binding capacity of the L. lactis MG1363 particles is about 100 %, and the relative percentages for the other LAB GEM particles are also shown. Approximately >90 % of the activity was retained after this fusion protein bound to LAB GEM particles (Fig. 5B). Successful binding was also confirmed by immunofluorescence microscopy, as shown in Additional file 1: Figure S4. When the LAB particles were incubated with a high concentration of QK-3LysM, the binding capacity was significantly increased (data not shown).
Fig. 5

Analysis of the binding efficiency of QK-3LysM. A Western blot analysis of the culture supernatant after binding assay (a) and the QK-3LysM loaded LAB GEM particles (b); the relative binding rate is shown for each LAB GEM particle. B Fibrinolytic activity analysis of QK-3LysM before and after binding assay; all data presented were mean ± SD of three replicate experiments. 1 L. lactis MG1363; 2 L. casei; 3 L. paracasei; 4 S. thermophilus; 5 L. bulgaricus ATCC 11842; 6 L. plantarum ST-III

Stability in simulated gastric juice

Simulated gastric juice (GJ) was used to test the stability of the free form Subtilisin QK-2 and the QK-3LysM displayed onto the surface of L. lactis MG1363 GEM particles. As shown in Fig. 6, the reduced activity of the loaded MG1363 GEM particles was less than 18 %, even after 30 min at pH 2.0, and the reduction was greater for the free form Subtilisin QK-2, which lost 63 % fibrinolytic activity compared to the positive control (Fig. 6).
Fig. 6

Stability analysis of different form of Subtilisin QK-2 in simulated gastric juice. The free form Subtilisin QK-2 (A) and QK-3LysM binding to the surface of L. lactis MG1363 GEM particles (B) were incubated with simulated gastric juice of pH 4.0 (GJ-pH 4) or pH 2.0 (GJ-pH 2). The samples incubated with PBS (pH 7.0) were used as positive control. All data presented were mean ± SD of three replicate experiments


Fibrinolytic enzymes derived from microorganisms have attracted more interest in thrombolytic therapy than typical thrombolytic agents, which have drawbacks, including the undesirable side effects, low specificity toward fibrin, and high cost [13]. Subtilisin QK-2 is a subtilisin-family serine protease, and previous studies have revealed that it is a type of effective thrombolytic reagent with highly exploitable potential [13]. In this study, Subtilisin QK-2 was first successfully expressed in two forms, including secretory expression and LAB GEM particles-surface display, using the NICE system in L. lactis.

Nattokinase is expressed in B. subtilis [14] and E. coli [15, 16]; however, complicated purification processes must be performed before the expressed enzyme can be applied for clinical use. Although the intracellular [17] and intercellular [18] expression of Nattokinase in L. lactis was studied, the recombinant strains contained antibiotic (chloramphenicol and erythromycin, respectively) resistance genes and thus, do not adhere to the real “food-grade” definition [5]. Without using antibiotics, Subtilisin QK-2 was expressed in L. lactis NZ3900 (pRF02), which was selected by the complementation of the lacF gene in this study, which allowed it to meet the food-grade requirements.

Leaky expression of the qk gene from the nisA promoter was observed in the recombinant strain L. lactis NZ3900. It has been proposed that this leaky expression is a property of the NICE system itself [19]. However, the reason for this phenomenon is unknown and requires further study.

Under the optimized induction conditions, the expression levels in L. lactis NZ3900 (pRF02H or pRF03H) and NZ9000 (pRF03H) were similar, regardless of the selection marker used. After 6 and 8 h of induction, the cell growth and production of Subtilisin QK-2 began to decrease, respectively (Additional file 1: Figure S2). However, it is not appropriate to compare the production levels after a long induction time in L. lactis because the plasmid stability may not be a key factor [20] that interferes with the production of Subtilisin QK-2.

As an alkaline protease, the optimal pH of Subtilisin QK-2 is approximately 8.5, and it is unstable in acidic environment. Because of the production of lactic acid during fermentation, the pH of the L. lactis culture decreases. During the fermentation of the recombinant L. lactis NZ9000 (pRF03H) strain, the pH decreased to 5.4, which may affect the expression of Subtilisin QK-2. This is confirmed by regulating the pH of the medium with NaOH. With a slightly alkaline (pH 7.3–7.9) medium, Subtilisin QK-2 had a stronger bioactivity (Fig. 3), which may be attributed to better folding as a result of the addition of NaOH. The same effect of the pH of the medium on the bioactivity of SCI-57 was reported previously [21].

A previous report [22] suggested that codon optimization strategies could be applied to expression systems with LAB as producer strains. In this study, a stronger fibrinolytic activity was found using codon optimization. Furthermore, codon optimization of both the entire sequence and the propeptide sequence only has the same effect (Fig. 3). However, no positive effect of the codon optimization on the yield of this enzyme was detected; and this may be attributed to the low expression level of QK or the low percentage of rare codons (approximately 6.5 %). Optimization of these 11 rare codons existed in the propeptide sequence may improve the activity of the propeptide and then promote the mature polypeptide to fold into the proper conformation, which may be more active or stable, ultimately leading to the same effect as codon optimization of the entire sequence. This also confirms the important role of the propeptide played in the folding process of the mature peptide [23]. Moreover, this finding may offer a new and less expensive method for codon optimization with a target protein similar to Subtilisin QK-2.

The display level of traditional surface display systems, which are based on the expression of proteins on the producer cell surface, is largely dependent on the efficiency of expression and translocation, and the host strain is a genetically modified organism [24]. However, the use of GMOs in applications that involve uncontrolled release into the environment, such as foods and vaccines, is less desirable or at least under debate [10]. To circumvent these problems, gram-positive enhancer matrix (GEM) particles can be used as substrates to bind externally added heterologous proteins by using a high-affinity binding domain. As the most often used binding domain, the LysM repeat exists in the C-terminal region of the major autolysin AcmA of L. lactis and was used in this study to display Subtilisin QK-2 onto various LAB GEM particles. For the N-terminus fusion (1LysM-QK), the detected protein band was larger than expected (Fig. 4), and the excess size was equal to the propeptide which should be removed during the translocation process of mature Subtilisin QK-2. Therefore, the propeptide was not cleaved because of the LysM repeat located between the signal peptide and the propeptide. This non-cleaved propeptide resulted in the loss of fibrinolytic activity for this fusion protein. By contrast, the LysM repeats fused to the C-terminus of Subtilisin QK-2 had no influence on the cleavage of the propeptide, and the fusion proteins were expressed at the expected size (Fig. 4) and retained their fibrinolytic activity (Table 1). The fibrinolytic activity of QK-1LysM and QK-3LysM was comparable (85.7 and 82.4 %, respectively) to the free Subtilisin QK-2 contained in the induced culture medium, which indicated that the added anchor domain (1 or 3 LysM repeats) had little impact on the conformation of QK. However, the production of the QK-5LysM fusion protein was lower and highly degraded (Fig. 4). The degradation may be related to the activity of endogenous surface housekeeping proteases, such as HtrA [25], and a greater number of LysM repeats could be more easily targeted compared to one or three repeats. In addition to degradation, the loss of fibrinolytic activity for the QK-5LysM may be attributed to the stereo-hindrance effect of a larger anchor domain. To protect the fusion proteins from degradation, htrA-deficient strains therefore represent possible solutions.

After incubation, QK-1LysM was able to bind to GEM particles; however, the binding was poor. With an increase in the number of LysM repeats, a clear increase in the binding affinity was observed in the binding assay of the QK-3LysM fusion protein. This finding is consistent with a previous report [10], in which potent binding to lactococcal GEM particles was obtained using two identical AcmA LysM domains. The binding capabilities of all LAB GEM particles were comparable (Fig. 5) and were higher than those of the natural LAB cells without chemical treatment (data not shown). This is because the binding of LysM-type repeats to peptidoglycans is hindered by other cell wall constituents that exist in the natural cell surface [12]. Most importantly, the binding capacity increased with a higher concentration of QK-3LysM fusion proteins, which improved the fibrinolytic activity of the same volume loaded onto LAB GEM particles. Compared to the free Subtilisin QK-2, the QK-3LysM displayed onto the surface of GEM particles was more stable in simulated gastric juice (Fig. 6). This indicated that the loaded GEM particles can protect Subtilisin QK-2 from degradation and retain considerable functionality after oral administration. Bound to LAB GEM particles, QK-3LysM does not need complex purification process and can be applied to oral administration without any additional adjuvant. Therefore, the lower cost of producing subtilisin loaded LAB GEM particles would contribute to their widespread application. The current administration method of other thrombolytic agents (such as Urokinase and Heparin) is injection and this route is prone to a number of problems and causes huge physical and psychological pressure for patients [26], compared to the gastric delivery of the subtilisin bound to LAB GEM particles.

The fibrinolytic enzyme Subtilisin QK-2 was successfully expressed in the potential probiotic, L. lactis. For the secretory expression of Subtilisin QK-2, to avoid potential complications with induction in vivo, it may be possible to preinduce L. lactis NZ3900 (pRF02) with nisin prior to oral administration. Treating L. lactis with a 1-h pulse of nisin can induce protein secretion for 10 h [27]. Then the recombinant strains can secrete this enzyme in the intestinal tract. Furthermore, L. lactis NZ3900 (pRF02) can secrete Subtilisin QK-2 without nisin induction, and this leaky expression may be considered a type of constitutive expression. To circumvent the use of a genetically modified organism and the degradation of free Subtilisin QK-2, the QK-LysM fusion protein (without His-tag) loaded LAB GEM particles can be used for oral administration without additional adjuvants. The highest binding capacity for lactococcal GEM particles is approximately 106 molecules per cell [10]; therefore, a much higher surface density can be obtained by incubation with the culture medium containing a higher concentration of fusion proteins. Additionally other functional proteins can be displayed simultaneously onto the same GEM particles by incubation with culture medium containing different LysM fusion proteins.


Subtilisin QK-2 was successfully expressed using lactic acid bacteria in two forms, secretory expression and surface display. For secretory expression, both pH modulation and codon optimization improved the bioactivity of this enzyme. In particular, no antibiotic was used in the recombinant strain L. lactis NZ3900 (pRF02), which attained the “food-grade” standard. For surface display, the fusion proteins retain fibrinolytic activity with the anchor domain LysM fused to the C-terminus, but not the N-terminus, of Subtilisin QK-2, and the QK-3LysM fusion protein performs best in binding assay. Compared to the free form, Subtilisin QK-2 loaded onto LAB GEM particles is more stable in simulated gastric juice. Using LAB, Subtilisin QK-2 may become popularized more easily and conveniently with minimal adverse effects, and it is a promising strategy for the prevention and control of thrombosis with the potential for widespread application.


Bacterial strains, plasmids, and culture conditions

The bacterial strains and plasmids used in this study are given in Table 2. Strains L. plantarum ST-III [28], L. lactis NZ9000 [20], and NZ3900 [20] and plasmids pNZ8048 [29] and pNZ8149 [30] were kind gifts from Prof. Shanjing Yao, College of Materials Science and Chemical Engineering, Zhejiang University. L. delbrueckii subsp. Bulgaricus ATCC 11842 [31] was a kind gift from Xiaoyan Liu, School of Life Science, Huaiyin Normal University. E. coli TOP10 (Invitrogen; Carlsbad, CA, USA) and B. subtilis QK02 (CCTCC, M203078) strains were grown in Luria–Bertani medium with shaking at 37 °C. L. lactis strains were grown statically in M17 medium (Merck) at 30 °C in tightly capped flasks supplemented with 0.5 % glucose (GM17) or 0.5 % lactose (LM17). Lactobacillus strains and S. thermophilus were grown in MRS broth (Merck) at 37 °C without aeration. Elliker broth [32] was used for the selection of lac+ L. lactis NZ3900 colonies. For plasmid selection in E. coli and L. lactis, chloramphenicol (Sigma) was added at 5 μg/ml.
Table 2

Bacterial strains and plasmids

Strain or plasmid

Relevant properties

Reference or source


 E. coli TOP10

Cloning host


 B. subtilis QK02

QK producing bacterium, wild strain


 L. lactis MG1363

Subsp. cremoris, plasmid-free

Our lab

 L. lactis NZ9000

Derivative of MG1363 with integration

nisRK into chromosome


 L. lactis NZ3900

Derivative of NZ3000 with integration

nisRK into chromosome; ∆lacF


 L. bulgaricus ATCC 11842

Type strain


 L. plantarum ST-III

Wild strain


 L. casei

Wild strain

Our lab

 L. paracasei

Wild strain

Our lab

 S. thermophilus

Wild strain

Our lab



ApR, pUC19 containing the optimized gene qk



CmR, P nisA , L. lactis expression vector



lacF, P nisA , L. lactis food grade expression vector



lacF, pNZ8149 derivate containing spUsp downstream of P nisA

This study


lacF, pRF01 with qk downstream of spUsp

This study


lacF, pRF02 containing qk with a His-tag

This study


CmR, pNZ8048 derivate carrying spUsp-qk downstream of P nisA

This study


CmR, pRF03 containing qk with a His-tag

This study


CmR, pRF03 containing qk’ with a His-tag

This study


CmR, pRF03 containing qkpro’ with a His-tag

This study


CmR, pRF03 derivate containing one LysM with a His-tag from acmA fused to the 3′ end of qk

This study


CmR, pRF06H derivate containing three LysM

This study


CmR, pRF06H derivate containing five LysM

This study


CmR, pRF03H containing one LysM from acmA between spUsp and qk

This study

DNA manipulation and transformation

Combined with lysozyme, genomic DNA and/or plasmids were extracted from B. subtilis and L. lactis strains using a rapid bacterial genomic DNA isolation kit (Sangon Biotech, Shanghai, China) and a rapid mini plasmid kit (Tiangen Biotech, Beijing, China), respectively. To study the effect of codon bias on the expression of Subtilisin QK-2 in L. lactis, codon optimization was performed using the JCat program [33] according to the protein sequence of Subtilisin QK-2 (GenBank: AJ579472.2). The codon-optimized gene of Subtilisin QK-2 (qk′, GenBank accession number KT725198) was synthesized by TsingKe Biological Technology (Wuhan, China) and was ligated into the pUC19 plasmid, resulting in pUC19-qk′. On the basis of the qk′, qkpro′ (GenBank accession number KT991841) containing the codon-optimized propeptide sequence only was obtained by overlap extension (SOE)-PCR. KOD Dash DNA polymerase (TOYOBO) was used to maintain the veracity of the PCR process. Restriction enzymes and T4 DNA ligase were purchased from TaKaRa and were used according to the manufacturer’s instructions. General molecular biological procedures were performed according to [34].

Construction of expression vectors and recombinant L. lacis strains

The primers used in this study for the amplification of target DNA fragments are listed in Table 3. The sp Usp gene, amplified from the chromosome of L. lactis MG1363 using primers P1 and P2, was cloned into NcoI and SphI-digested pNZ8149 to obtain plasmid pRF01 (Table 2). Primers P3 and P4 or P5 were used to amplify the qk gene encoding the propeptide and the mature QK-2 from the genome of B. subtilis QK02. Then, the resulting genes were digested with KpnI and XbaI and finally introduced into pRF01 to obtain plasmids pRF02 and pRF02H (Table 2). The sp Usp-qk was obtained from pRF02 or pRF02H using NcoI and XbaI digestion, and this fusion gene was introduced into the same digested pNZ8048 to obtain plasmids pRF03 or pRF03H (Table 2). Primers P6 and P7 were used to amplify the codon-optimized qk′ gene from the plasmid pUC19-qk′. The resulting fragment was introduced into pRF03H by KpnI and XbaI digestion to obtain plasmid pRF04H (Table 2), which contained the codon-optimized qk′ instead of the wild-type qk gene. The optimized propeptide gene sequence (pro′) was amplified from pUC19-qk′ using primers P6 and P8 containing 15 overlapping nucleotides with the 5′ end of the mature peptide gene sequence in wild-type qk gene. The mature peptide gene sequence (M) was amplified from plasmid pRF03H using primers P9 and P10. Using primers P6 and P10, the codon-optimized propeptide only gene sequence qkpro′ was obtained by overlap PCR with the pro′ and M sequences as templates. Then, the qkpro′ was introduced into pRF03H by KpnI and XbaI digestion to obtain plasmid pRF05H (Table 2). One or three LysM repeats can be amplified from the chromosome of L. lactis MG1363 using primers P11 and P12 or P13. Then, these repeats were introduced into plasmid pRF03 by XbaI and SacI digestion to obtain plasmids pRF06H and pRF07H (Table 2), respectively. Using the chromosome of L. lactis MG1363, primers P11 and P14 were used to amplify three LysM repeats containing 15 overlapping nucleotides with the 5′ end of the second LysM repeat in acmA gene. Primers P13 and P15 were used to amplify the last two LysM repeats from the chromosome of L. lactis MG1363. Using primers P11 and P13, a gene fragment containing five LysM repeats was obtained by overlap PCR with the above three and two repeats as templates. The obtained five LysM repeats were also introduced into plasmid pRF03 by XbaI and SacI digestion to obtain plasmid pRF08H (Table 2). The first LysM repeat was amplified from the chromosome of L. lactis MG1363 using primers P16 and P17 and was then introduced into plasmid pRF03H by SphI and KpnI digestion to obtain plasmid pRF09H (Table 2), which contained one LysM repeat at the 5′ end of the qk gene. All plasmids were sequenced at TsingKe Biological Technology (Wuhan, China) to confirm the veracity and the correct open reading frame. In addition to L. lactis NZ3900 containing plasmid pRF02 or pRF02H, pRF03H was introduced into NZ3900, and the transformants were selected on GM17 plates containing chloramphenicol. All plasmids containing the chloramphenicol resistance gene constructed in this study (Table 2) were introduced into L. lactis NZ9000 and selected as described above.
Table 3

Primers used in this study


Sequencea (5′–3′)



































aUnderlying (single) indicates the restriction enzyme sites; Bold italics indicates the His6-tag sequence; Stop codons (in italics) were introduced to end the translation; Boldface indicates primer extensions necessary for overlap extension


For the secretory expression of the free Subtilisin QK-2 or the fusion proteins, overnight cultures of the recombinant L. lactis NZ3900 harboring the plasmid pRF02 or pRF02H were diluted 1:25 into fresh M17 medium containing 0.5 % lactose. For other recombinant strains, overnight cultures were diluted 1:25 into fresh M17 medium containing 0.5 % glucose and 5 μg/ml of chloramphenicol. Strains were incubated at 30 °C without shaking. Nisin (Sigma) was added into the culture during the early exponential phase of growth (OD600 ≈ 0.5) to induce expression. To regulate the pH of the medium, 10 % culture volume of 5 N NaOH was added once at the indicated time (1, 2, or 3 h) after induction. After induction, the culture was centrifuged and both the supernatant culture and sonicated cell lysate were used for the detection and quantification of the enzyme [18].

Production of LAB GEM particles and binding conditions

Chemical pretreatment of LAB cells, including L. lactis MG1363, L. bulgaricus ATCC 11842, L. plantarum ST-III, L. casei, L. paracasei, and S. thermophiles, was performed with 10 % TCA. Briefly, cells of the stationary-phase cultures were collected by centrifugation and washed twice with 0.3 volume PBS. Then, cells were resuspended in 0.2 volume of 10 % TCA solution and boiled for 30 min. Next, the cells were washed three times in PBS with vigorous vortexing. After washing, the cells were resuspended in PBS at a final concentration of 2.5 × 1010 GEM particles/ml, as determined using a Burker-Turk hemocytometer. GEM particles were either used immediately for binding experiments or stored at −80 °C until use.

For binding experiments, 2.5 × 109 GEM particles were added to 0.5–50 ml of cell-free supernatant containing fusion proteins and incubated for 30–60 min at room temperature in an end-over-end rotator. When needed, culture medium containing the fusion proteins was concentrated prior to binding using an Amicon Ultra-15 ml (Millipore). After binding, the GEM particles were collected by centrifugation and washed three times with PBS. To test the binding efficiency, GEM particles were analyzed using immunofluorescence microscopy, western blotting or enzymatic activity analysis.

Measure of fibrinolytic activity

Subtilisin QK-2 shows high efficiency for directly cross-linked fibrin; therefore, the fibrinolytic activity of the above samples was assayed with the standard fibrin plate method using urokinase as the standard [1]. Holes were made on the fibrin plate prepared according to the previously used method [35]. For both the cell-free culture medium containing free Subtilisin QK-2 and the GEM particles bound to the LysM-QK fusion proteins, 30 μl of the samples was dropped in the holes. Then, the plate was incubated for 18 h at 37 °C, and the fibrinolytic activity was determined by measuring the diameter of the clear zone according to the standard curve of urokinase (Sigma).

Western blot analysis

The culture medium containing free Subtilisin QK-2 or the GEM particles bound to the fusion proteins were resuspended in SDS-PAGE loading buffer and boiled for 10 min. The proteins were separated by 12 % SDS-PAGE and transferred onto a PVDF membrane (Millipore). The membrane was blocked overnight in 5 % solution of skim milk powder in Tris-buffered saline containing 0.05 % tween-20 (TBST) and then incubated in TBST containing 1:2000 diluted mouse His-tag monoclonal antibody (Proteintech, Wuhan, China) for 2 h with gentle shaking. After washing three times with TBST buffer, the membrane was incubated with 1:6000 diluted peroxidase-conjugated goat anti-mouse IgG (H + L) (Proteintech, Wuhan, China) for 1 h. After washing, the membrane was subjected to ECL hypersensitive reagents (Pierce, USA) and then exposed and developed.

Immunofluorescence microscopy

To further confirm that the QK and LysM fusion proteins can bind to the surface of GEM particles after the binding assay, the pellets were resuspended in 100 μl PBS containing 1 % BSA and mouse His-tag monoclonal antibody diluted 1:50. After incubation for 1 h at room temperature, the GEM particles were washed three times with 1 ml PBS. Next, they were combined with 100 μl PBS containing 1 % BSA and FITC-conjugated goat anti-mouse IgG (H + L) (Proteintech, Wuhan, China) diluted 1:100 and incubated for 1 h. GEM particles were washed three times with PBS, placed on a glass slide, air-dried and heat-fixed. Analysis was performed on a confocal microscopy (Olympus Fluoview IX70).

Stability test

Simulated gastric juice (GJ) was prepared as previously described [36] containing 3 mg/ml pepsin (Sigma) and the pH was adjusted to 2.0 or 4.0. A 500 μl volume of 10-fold concentrated cell-free culture medium containing free Subtilisin QK-2 and 500 μl loaded MG1363 GEM particles incubated with the same concentrated cell-free culture medium containing QK-3LysM fusion protein were combined with the same volume of simulated GJ or PBS (pH 7.0; positive control), respectively, and incubated at room temperature for 30 min. Then, the mixture was used for the analysis of fibrinolytic activity as described above.

Codon usage analysis

A graphical codon usage analyzer ( [37] was used to compare the codon usage in the Subtilisin QK-2 gene qk with the codon usage table of L. lactis MG1363 ( Codon usage between 10 and 20 % for a particular codon is considered as “rather low” and below 10 % as “very low” [20].


Authors’ contributions

RFM designed the study under the guidance of YFW and carried out the experiments with the help of KPZ and ZWH. RFM drafted and corrected the manuscript. All authors read and approved the final manuscript.


This work was financially supported by the National Basic Research Program of China (973 Program, No. 2011CB504800) and we heartily thank Prof. Shanjing Yao and Xiaoyan Liu for providing strains and plasmids.

Competing interests

The authors declare that they have no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

State Key Laboratory of Virology, College of Life Sciences, Wuhan University


  1. Ko JH, Yan JP, Zhu L, Qi YP. Identification of two novel fibrinolytic enzymes from Bacillus subtilis QK02. Comp Biochem Physiol C: Toxicol Pharmacol. 2004;137:65–74.Google Scholar
  2. Ko J, Yan J, Zhu L, Qi Y. Subtilisin QK, a fibrinolytic enzyme, inhibits the exogenous nitrite and hydrogen peroxide induced protein nitration, in vitro and in vivo. J Biochem Mol Biol. 2005;38:577–83.View ArticleGoogle Scholar
  3. Yan F, Yan J, Sun W, Yao L, Wang J, Qi Y, Xu H. Thrombolytic effect of subtilisin QK on carrageenan induced thrombosis model in mice. J Thromb Thrombolysis. 2009;28:444–8.View ArticleGoogle Scholar
  4. Pontes DS, de Azevedo MS, Chatel JM, Langella P, Azevedo V, Miyoshi A. Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems. Protein Expr Purif. 2011;79:165–75.View ArticleGoogle Scholar
  5. Peterbauer C, Maischberger T, Haltrich D. Food-grade gene expression in lactic acid bacteria. Biotechnol J. 2011;6:1147–61.View ArticleGoogle Scholar
  6. Le Loir Y, Azevedo V, Oliveira SC, Freitas DA, Miyoshi A, Bermudez-Humaran LG, Nouaille S, Ribeiro LA, Leclercq S, Gabriel JE, et al. Protein secretion in Lactococcus lactis: an efficient way to increase the overall heterologous protein production. Microb Cell Fact. 2005;4:2.View ArticleGoogle Scholar
  7. Piard JC, Hautefort I, Fischetti VA, Ehrlich SD, Fons M, Gruss A. Cell wall anchoring of the Streptococcus pyogenes M6 protein in various lactic acid bacteria. J Bacteriol. 1997;179:3068–72.Google Scholar
  8. van Roosmalen ML, Kanninga R, El Khattabi M, Neef J, Audouy S, Bosma T, Kuipers A, Post E, Steen A, Kok J, et al. Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria. Methods. 2006;38:144–9.View ArticleGoogle Scholar
  9. Ramasamy R, Yasawardena S, Zomer A, Venema G, Kok J, Leenhouts K. Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations. Vaccine. 2006;24:3900–8.View ArticleGoogle Scholar
  10. Bosma T, Kanninga R, Neef J, Audouy SA, van Roosmalen ML, Steen A, Buist G, Kok J, Kuipers OP, Robillard G, Leenhouts K. Novel surface display system for proteins on non-genetically modified gram-positive bacteria. Appl Environ Microbiol. 2006;72:880–9.View ArticleGoogle Scholar
  11. Raha AR, Varma NR, Yusoff K, Ross E, Foo HL. Cell surface display system for Lactococcus lactis: a novel development for oral vaccine. Appl Microbiol Biotechnol. 2005;68:75–81.View ArticleGoogle Scholar
  12. Steen A, Buist G, Leenhouts KJ, El Khattabi M, Grijpstra F, Zomer AL, Venema G, Kuipers OP, Kok J. Cell wall attachment of a widely distributed peptidoglycan binding domain is hindered by cell wall constituents. J Biol Chem. 2003;278:23874–81.View ArticleGoogle Scholar
  13. Wu B, Wu L, Chen D, Yang Z, Luo M. Purification and characterization of a novel fibrinolytic protease from Fusarium sp. CPCC 480097. J Ind Microbiol Biotechnol. 2009;36:451–9.View ArticleGoogle Scholar
  14. Wei X, Zhou Y, Chen J, Cai D, Wang D, Qi G, Chen S. Efficient expression of nattokinase in Bacillus licheniformis: host strain construction and signal peptide optimization. J Ind Microbiol Biotechnol. 2015;42:287–95.View ArticleGoogle Scholar
  15. Liang X, Jia S, Sun Y, Chen M, Chen X, Zhong J, Huan L. Secretory expression of nattokinase from Bacillus subtilis YF38 in Escherichia coli. Mol Biotechnol. 2007;37:187–94.View ArticleGoogle Scholar
  16. Chiang CJ, Chen HC, Chao YP, Tzen JT. Efficient system of artificial oil bodies for functional expression and purification of recombinant nattokinase in Escherichia coli. J Agric Food Chem. 2005;53:4799–804.View ArticleGoogle Scholar
  17. Chiang SS, Liu CF, Ku TW, Mau JL, Lin HT, Pan TM. Use of murine models to detect the allergenicity of genetically modified Lactococcus lactis NZ9000/pNZPNK. J Agric Food Chem. 2011;59:3876–83.View ArticleGoogle Scholar
  18. Liang X, Zhang L, Zhong J, Huan L. Secretory expression of a heterologous nattokinase in Lactococcus lactis. Appl Microbiol Biotechnol. 2007;75:95–101.View ArticleGoogle Scholar
  19. Fu RY, Chen J, Li Y. Heterologous leaky production of transglutaminase in Lactococcus lactis significantly enhances the growth performance of the host. Appl Environ Microbiol. 2005;71:8911–9.View ArticleGoogle Scholar
  20. Maischberger T, Mierau I, Peterbauer CK, Hugenholtz J, Haltrich D. High-level expression of Lactobacillus beta-galactosidases in Lactococcus lactis using the food-grade, nisin-controlled expression system NICE. J Agric Food Chem. 2010;58:2279–87.View ArticleGoogle Scholar
  21. Ng DT, Sarkar CA. Nisin-inducible secretion of a biologically active single-chain insulin analog by Lactococcus lactis NZ9000. Biotechnol Bioeng. 2011;108:1987–96.View ArticleGoogle Scholar
  22. Fuglsang A. Lactic acid bacteria as prime candidates for codon optimization. Biochem Biophys Res Commun. 2003;312:285–91.View ArticleGoogle Scholar
  23. Tang B, Nirasawa S, Kitaoka M, Marie-Claire C, Hayashi K. General function of N-terminal propeptide on assisting protein folding and inhibiting catalytic activity based on observations with a chimeric thermolysin-like protease. Biochem Biophys Res Commun. 2003;301:1093–8.View ArticleGoogle Scholar
  24. Samuelson P, Gunneriusson E, Nygren PA, Stahl S. Display of proteins on bacteria. J Biotechnol. 2002;96:129–54.View ArticleGoogle Scholar
  25. Poquet I, Saint V, Seznec E, Simoes N, Bolotin A, Gruss A. HtrA is the unique surface housekeeping protease in Lactococcus lactis and is required for natural protein processing. Mol Microbiol. 2000;35:1042–51.View ArticleGoogle Scholar
  26. Yalkowsky SH, Krzyzaniak JF, Ward GH. Formulation-related problems associated with intravenous drug delivery. J Pharm Sci. 1998;87:787–96.View ArticleGoogle Scholar
  27. Bermudez-Humaran LG, Langella P, Commissaire J, Gilbert S, Le Loir Y, L’Haridon R, Corthier G. Controlled intra- or extracellular production of staphylococcal nuclease and ovine omega interferon in Lactococcus lactis. FEMS Microbiol Lett. 2003;224:307–13.View ArticleGoogle Scholar
  28. Wang Y, Chen C, Ai L, Zhou F, Zhou Z, Wang L, Zhang H, Chen W, Guo B. Complete genome sequence of the probiotic Lactobacillus plantarum ST-III. J Bacteriol. 2011;193:313–4.View ArticleGoogle Scholar
  29. Bahey-El-Din M, Casey PG, Griffin BT, Gahan CG. Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8(+) T cells against Listeria monocytogenes in the murine infection model. Vaccine. 2008;26:5304–14.View ArticleGoogle Scholar
  30. De Ruyter P, Kuipers OP, De Vos WM. Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl Environ Microbiol. 1996;62:3662–7.Google Scholar
  31. Galat A, Dufresne J, Combrisson J, Thépaut J, Boumghar-Bourtchai L, Boyer M, Fourmestraux C. Novel method based on chromogenic media for discrimination and selective enumeration of lactic acid bacteria in fermented milk products. Food Microbiol. 2015;55:86–94.View ArticleGoogle Scholar
  32. Sheng J, Ling P, Wang F. Constructing a recombinant hyaluronic acid biosynthesis operon and producing food-grade hyaluronic acid in Lactococcus lactis. J Ind Microbiol Biotechnol. 2015;42:197–206.View ArticleGoogle Scholar
  33. Grote A, Hiller K, Scheer M, Munch R, Nortemann B, Hempel DC, Jahn D. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res. 2005;33:W526–31.View ArticleGoogle Scholar
  34. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory Press; 1989.Google Scholar
  35. Astrup T, Mullertz S. The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys. 1952;40:346–51.View ArticleGoogle Scholar
  36. Charteris WP, Kelly PM, Morelli L, Collins JK. Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. J Appl Microbiol. 1998;84:759–68.View ArticleGoogle Scholar
  37. Fuhrmann M, Hausherr A, Ferbitz L, Schodl T, Heitzer M, Hegemann P. Monitoring dynamic expression of nuclear genes in Chlamydomonas reinhardtii by using a synthetic luciferase reporter gene. Plant Mol Biol. 2004;55:869–81.View ArticleGoogle Scholar


© The Author(s). 2016